%0 Journal Article %A Chénangnon F. Tovissodé %A Bruno E. Lokonon %A Romain Glèlè Kakaï %T On the use of growth models for forecasting epidemic outbreaks with application to COVID-19 data %D 2020 %R 10.1101/2020.08.16.20176057 %J medRxiv %P 2020.08.16.20176057 %X The initial phase dynamics of an epidemic without containment measures is commonly well modeled using exponential growth models. However, in the presence of containment measures, the exponential model becomes less appropriate. Under the implementation of an isolation measure for detected infectives, we propose to model epidemic dynamics by fitting a flexible growth model curve to reported positive cases and to infer the overall epidemic dynamics by introducing information on the detection/testing effort and recovery and death rates. The resulting modeling approach is close to the SIQR (Susceptible-Infectious-Quarantined-Recovered) model framework. We focused on predicting the peaks (time and size) in positive cases, actives cases and new infections. We applied the approach to data from the COVID-19 outbreak in Italy. Fits on limited data before the observed peaks illustrate the ability of the flexible growth model to approach the estimates from the whole data.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicableFunding StatementNo findingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data considerd in this manuscript are available online at: https://github.com/CSSEGISandData/COVID-19/tree/master/csse_covid_19_data/csse_covid_19_time_series https://github.com/CSSEGISandData/COVID-19/tree/master/csse_covid_19_data/csse_covid_19_time_series %U https://www.medrxiv.org/content/medrxiv/early/2020/08/18/2020.08.16.20176057.full.pdf